#CannabisThailand

A major international analysis finds that regular cannabis use may pose significant heart risks, at times rivaling or exceeding those associated with cocaine. The study, published in Heart, aggregates data from thousands of studies and millions of individuals to reassess cannabis’s cardiovascular safety. For Thailand, where cannabis policy is evolving rapidly, the findings carry urgent implications for users, health professionals, and policymakers.

Historically, cannabis has been portrayed as a natural remedy with relatively mild side effects. In Thailand, cannabis products are increasingly present in wellness venues and traditional medicine circuits. The new evidence suggests that regular cannabis use can increase the likelihood of heart attack, stroke, and fatal cardiovascular events. Scientists emphasize that these risks persist even after accounting for tobacco, alcohol, and other substances, underscoring the complexity of cannabis’s impact on the heart.

A groundbreaking new study has sent shockwaves through the medical and public health communities by revealing that cannabis use could be more dangerous for the heart than cocaine. The research, published recently in the esteemed journal Heart, synthesizes data from over 432 million individuals and challenges widespread perceptions about the safety of cannabis, especially as legalization expands globally. For Thailand, where decriminalization and policy debates about cannabis are accelerating, the study’s findings carry urgent implications for users and policymakers alike.

A new wave of scientific concern is cresting over cannabis use, as recent research finds that using marijuana—whether smoked or eaten in gummies—is directly associated with significant risks to heart health. The findings, published in JAMA Cardiology and led by researchers at the University of California, San Francisco (UCSF), upend the common belief that cannabis is a safer or even harmless alternative to tobacco, particularly as legalization and recreational use continue to rise worldwide, including in Thailand.

A new study raises serious concerns about cannabis and heart health. Research led by investigators at UCSF and published in JAMA Cardiology shows that cannabis use—whether smoked or consumed as edibles—may impair cardiovascular function. The findings challenge the idea that cannabis is a safer alternative to tobacco, especially as legalization and consumer use expand globally, including in Thailand.

For Thai readers, the study arrives at a moment when policy, health messaging, and potential economic benefits of cannabis are hotly debated. Thailand has moved to legalize certain cannabis activities, creating a local landscape where public health guidance needs to keep pace with evolving regulations. The new evidence underscores the importance of clear information for patients, clinicians, and regulators.

A UCSF study shows regular cannabis use, whether smoked or eaten, may impair cardiovascular health to a degree similar to tobacco. Published in JAMA Cardiology, the findings highlight potential risks that matter for Thai readers as the country debates cannabis policy and market growth.

In Thailand, cannabis reform began in 2022, with a rapid expansion of dispensaries, edibles, and wellness products. The new data from the United States adds scientific nuance to ongoing debates about benefits, risks, and regulation in a setting where public health messaging is still catching up with industry momentum. Data from Thai health authorities indicate a growing number of cannabis-related businesses, especially in major cities and tourist areas. Public health messaging has tended to emphasize economic opportunity and wellness, underscoring the need for balanced information about cardiovascular risks.

A newly released study by University of California San Francisco has uncovered compelling evidence that regular cannabis use, whether smoked or eaten as edibles, poses significant risks to cardiovascular health—on par with those seen in tobacco smokers. The findings, published in JAMA Cardiology on May 28, hold broad implications for communities worldwide, including Thailand, where cannabis reform remains a subject of careful debate and rapid market growth.

The research is particularly significant given that Thailand became the first Asian nation to decriminalise cannabis in 2022, sparking a “green rush” of dispensaries, edible products, and wellness treatments across the country. However, as debates over the benefits and drawbacks of cannabis legalization intensify, the new UCSF data brings overdue scientific scrutiny to the long-term health implications for the Thai public.